课题基金 / 基金详情

A Randomized Controlled Trial to Evaluate Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes

A Randomized Controlled Trial to Evaluate Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes
评估早期间歇强化胰岛素治疗作为 2 型糖尿病有效治疗方法的随机对照试验
批准号:
290976
负责人:
Retnakaran Ravi R
金额:
$94.52万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-09-01 至 2018-09-01

项目摘要

项目成果

Retnakaran Ravi R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Currently, approximately 3 million Canadians are affected by type 2 diabetes (T2DM) and it has been projected that this prevalence may increase to 1 in 8 Canadians by 2020. The central problem in T2DM is an inability of the beta-cells of the pancreas to p
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Community-based Preconception Lifestyle Intervention to prevent Gestational Diabetes Mellitus in Women living in India
  • 批准号:
    494564
  • 项目类别:
    Operating Grants
  • 资助金额:
    $45.53万
  • 财政年份:
    2023
  • 负责人:
    Retnakaran Ravi R
  • 依托单位:
The Evolution of Diabetes Risk in Canadian Women following Glucose Intolerance in Pregnancy
  • 批准号:
    494175
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Retnakaran Ravi R
  • 依托单位:
Preconception Lifestyle Intervention by Community Health Workers for the Prevention of Gestational Diabetes Mellitus: A Randomized Clinical Trial
  • 批准号:
    461671
  • 项目类别:
    Operating Grants
  • 资助金额:
    $38.73万
  • 财政年份:
    2022
  • 负责人:
    Retnakaran Ravi R
  • 依托单位:
Collaborative Care Initiated Prior to Conception by Public Health Nurses for the Prevention of Gestational Diabetes Mellitus in Canadian Women
  • 批准号:
    461931
  • 项目类别:
    Operating Grants
  • 资助金额:
    $25.13万
  • 财政年份:
    2022
  • 负责人:
    Retnakaran Ravi R
  • 依托单位:
海外基金